SARS News and Research

RSS

No evidence pregnancy increases the risk of COVID-19 morbidity or severity

Albeit pregnancy is generally considered a significant risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and more severe coronavirus disease (COVID-19) outcomes, a recent study by a multinational team of researchers shows that symptoms are generally comparable between pregnant and non-pregnant cohorts of women – with the exception of gastrointestinal symptoms. This paper is currently available on the medRxiv* preprint server.

23 Aug 2020

Pfizer/BioNTech COVID-19 vaccine candidate BNT162b2 profiled for large scale clinical trials

Although two RNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidates elicited similar, dose-dependent neutralizing antibody titers in both younger and older adults, a recent study by researchers from the U.S. and Germany has shown that BNT162b2 is associated with less systemic reactogenicity in elderly individuals – supporting its selection for further phase 2/3 clinical trials. The study is currently available on medRxiv* preprint server.

23 Aug 2020

Scientific review on on link between air pollution and COVID-19

Researchers at Harvard T. H. Chan School of Public Health, Harvard University, and the Dana-Farber Cancer Institute have conducted a “state-of-the-science” review of the evidence available on potential associations between exposure to air pollution and health outcomes in coronavirus disease 2019 (COVID-19).

23 Aug 2020

Raccoon dogs potential intermediate host for SARS-CoV-2

Researchers at the Friedrich Loeffler Institute in Germany have conducted a study demonstrating that raccoon dogs were a potential intermediate host in the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

23 Aug 2020

Self-collected saliva and deep nasal swabs are equally effective for detecting SARS-CoV-2

Self-collected saliva and deep nasal swabs collected by healthcare providers are equally effective for detecting SARS-CoV-2, the virus that causes COVID-19, according to a new study conducted by ARUP Laboratories and University of Utah Health.

21 Aug 2020

Genomic analysis reveals vulnerability of many animal species to SARS-CoV-2 infection

Humans are not the only species facing a potential threat from SARS-CoV-2, the novel coronavirus that causes COVID-19, according to a new study from the University of California, Davis.

21 Aug 2020

New COVID-19 pooling test detects asymptomatic carriers

A new peer-reviewed study published in Science Advances confirms the success of a new COVID-19 pooling test that identifies all positive subjects, including asymptomatic carriers, in a single round of testing.

21 Aug 2020

Nasal vaccine effective in preventing COVID-19 infection in mice

Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus.

21 Aug 2020

Study offers insights into immune reactions in severe COVID-19

Researchers may have come one step closer toward understanding how the immune system contributes to severe COVID-19.

21 Aug 2020

DNA nanoswitches may provide an inexpensive platform to rapidly detect emerging viruses

Programmable DNA nanoswitches that bind to viral RNA in human body fluids may provide an inexpensive platform to rapidly detect a wide variety of emerging viruses, including SARS-CoV-2, according to a new study.

21 Aug 2020

Researchers find clues to successful immune response in the T cells of COVID-19 patients

When news about a novel coronavirus switched from a chronicle of its progress in China to headlines about a worldwide COVID-19 pandemic, Gladstone Institutes scientist Nadia Roan, PhD, was in the midst of publishing several papers on T cells and their role in HIV spread and long-lasting infections.

21 Aug 2020

Researchers validate novel flavivirus identification test

There are more than 70 species of flavivirus, and many cause diseases in humans and animals, including dengue, Zika and yellow fever viruses.

21 Aug 2020

VUMC receives $34 million grant for nationwide convalescent plasma study

Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of "convalescent plasma" as a treatment for COVID-19.

21 Aug 2020

Study: Many COVID-19 patients suffer cardiovascular damage even after recovery

One of the most harrowing effects of COVID-19 is severe damage to the lungs, which makes breathing hard or impossible for those who're severely affected.

21 Aug 2020

DeSantis says COVID is a lower risk for school-aged kids than flu

Even as his state is a hotbed for COVID-19, Florida Gov. Ron DeSantis has been pushing schools to reopen so parents have the choice of sending children back to the classroom or keeping them home to learn virtually.

21 Aug 2020

SARS-CoV-2 ORF9c responsible for immune evasion and efficient infection of host

A recent study by researchers at the Sanford Burnham Prebys Medical Discovery Institute and the University of California San Francisco and published on the preprint server bioRxiv in August 2020 shows that a protein encoded by the subgenomic sequence ORF9c of SARS-CoV-2 is responsible for the low antiviral response in infected humans, enabling the successful replication of the virus in the host.

21 Aug 2020

AnteoTech's COVID-19 antigen and Flu A&B test detects SARS-Cov-2, influenza in less than 15 minutes

AnteoTech Ltd has successfully developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests that can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes.

21 Aug 2020

Macaques show low neutralizing antibody and cellular immune response to SARS-CoV-2

A new study published on the preprint server bioRxiv* in August 2020 presents a cynomolgus macaque model that develops symptomatic SARS-CoV-2 infection in a mild form, with low or no antibody responses, making it suitable to study human responses to vaccines and drugs targeting the virus.

21 Aug 2020

Researchers compare COVID-19 transmission risk when singing, speaking and breathing

Now, a new study* set to determine if singing and playing of woodwind and brass instruments produce more respiratory droplets and aerosols than speaking. Further, they want to know if the size and temperature of the venue will make a difference in the accumulation of aerosol droplets in the air.

21 Aug 2020

Bioinformatics identifies key genes and cellular pathways in COVID-19

The COVID-19 pandemic is showing no signs of waning or extinction anytime soon. Now, a new study published on the preprint server bioRxiv* in August 2020 shows a new bioinformatics approach to studying the pathogenesis of this disease, by uncovering the differentially expressed genes (DEGs) and cell signaling pathways that cause the disease characteristics. This will help develop better therapies to counter the effects of these genes.

20 Aug 2020

SARS News and Research

No evidence pregnancy increases the risk of COVID-19 morbidity or severity

Pfizer/BioNTech COVID-19 vaccine candidate BNT162b2 profiled for large scale clinical trials

Scientific review on on link between air pollution and COVID-19

Raccoon dogs potential intermediate host for SARS-CoV-2

Self-collected saliva and deep nasal swabs are equally effective for detecting SARS-CoV-2

Genomic analysis reveals vulnerability of many animal species to SARS-CoV-2 infection

New COVID-19 pooling test detects asymptomatic carriers

Nasal vaccine effective in preventing COVID-19 infection in mice

Study offers insights into immune reactions in severe COVID-19

DNA nanoswitches may provide an inexpensive platform to rapidly detect emerging viruses

Researchers find clues to successful immune response in the T cells of COVID-19 patients

Researchers validate novel flavivirus identification test

VUMC receives $34 million grant for nationwide convalescent plasma study

Study: Many COVID-19 patients suffer cardiovascular damage even after recovery

DeSantis says COVID is a lower risk for school-aged kids than flu

SARS-CoV-2 ORF9c responsible for immune evasion and efficient infection of host

AnteoTech's COVID-19 antigen and Flu A&B test detects SARS-Cov-2, influenza in less than 15 minutes

Macaques show low neutralizing antibody and cellular immune response to SARS-CoV-2

Researchers compare COVID-19 transmission risk when singing, speaking and breathing

Bioinformatics identifies key genes and cellular pathways in COVID-19

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News